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INTRODUCTION
Despite all efforts, the outcome of patients suffering from highly malignant neuroepithelial brain tumors remains dismal. Treatment difficulties arise from the main characteristics of these glial tumors such as rapid growth, extensive tissue invasion, and cell heterogeneity. Histological and immunocytochemistry methods [1] and more recently gene expression arrays [2] reveal that the behavior of these tumor cells appears to exhibit a dichotomy between proliferation and migration. That is, the same cell can either proliferate or migrate, yet not both at the same time, which should greatly influence the spatio-temporal dynamics of the malignant biosystem. Therefore, analyzing the impact of environmental factors on gene expression changes, which in turn are expected to regulate the phenotypic 'switch' from proliferation to migration, is key to a better understanding of tumor behavior and necessary in order to develop predictive modeling platforms for clinical applications.
As a first step, we employ here a previously developed 2D agent-based model of a virtual multicellular brain tumor system [3, 4] , which has been augmented to take into account explicitly molecular level dynamics. Our modeling platform is particular suitable for this purpose due to its 'monoclonal' nature, i.e., it focuses on the behavior of a population of homogeneous cells. To render our model tractable, the focus of our very simplified gene network is centered on the behavior of two genes only, namely Tenascin C and PCNA, which are chosen based on their reported roles during proliferation and migration of glioma cells. More specifically, Tenascin C is a an extracellular matrix glycoprotein known to be over-expressed in human gliomas [5, 6] . Further, it has been Yuri Mansury and Thomas S. Deisboeck: "Gene Expression Profiles in an Agent-Based Tumor Model" 5 demonstrated in vitro that migration is stimulated when human SF-767 glioma cells are placed on Tenascin C [7] . In contrast, the gene expression of proliferating cell nuclear antigen (PCNA) markedly rises during G1/S phase, thus serves as an indicator of proliferation activities [8] . High levels of PCNA have been shown to correlate with histological grade and poor prognosis in glioma patients [9, 10] .
By calibrating the expression of both genes using experimental data for the migratory phenotype while generating the gene expression for proliferating and quiescent cells as the model output, numerical results of the model confirm that among the migratory phenotype the expression of Tenascin C is indeed consistently higher, while they reveal the reverse for the proliferating tumor cells, which exhibit consistently higher expression of gene PCNA. In our particular modeling setup, this genetic switch, determining the cellular phenotype, can be explained by the tendency for migrating cells to encounter higher level of hypoxia than their proliferating peers. We then show that these molecular level dynamics can be directly linked to the tumor diameter, i.e., to the structural characteristic at the multicellular level. More specifically, in the presence of abundant nutrients, the gene expression profiles indicate a breaking point in the time series after which we find robust (i) positive correlations between tumor diameter and the expression of Tenascin C, and (ii) negative correlations between the former and PCNA expression, both as statistical averages for the entire pool of viable tumor cells.
Furthermore, during tumor invasion towards the geographic region of abundant nutrients, these molecular dynamics are accompanied by the emergence of a structural asymmetry in the rim of the growing tumor. The numerical results therefore support the notion that in the presence of these distinct microenvironmental conditions the migratory phenotype is crucial for the tumor system's macrocopic expansion and its regional structural patterns.
In addition, detrended fluctuation analysis (DFA) suggests that the gene expression profile of a phenotypically mixed cell population has a higher predictive value than that of a virtual tumor specimen that is divided into separate migrating and proliferating phenotypic subsets. Lastly, dividing the tumor into distinct geographic regions of interest (ROI) reveals that the quadrant close to the nutrient-abundant region, which also harbors the macroscopically conspicuous rim area, is representative for the entire tumor in terms of DFA and molecular-structural correlation results whereas the geographically opposite ROI is not.
In the next section we will first describe the mathematical model in more detail followed by the specific oncology concept implemented here.
MATHEMATICAL MODEL

A. Algorithm
The complete details of our agent-based model are described elsewhere [3, 4, 11] . Briefly:
• Microenvironment: environmental variables in our model consist of nutrient levels, toxic metabolites, and mechanical confinements. First, nutrient sources evolve according to the following equation of motion:
, with g φ representing the constant rate of nutrient replenishment, D φ the nutrient diffusion coefficient, and r φ the nutrient depletion rate. Similarly, the levels of toxic metabolites are also updated using a linear difference equation:
Finally, the dynamic evolution of mechanical confinements represents the 'adaptive grid lattice' property of the host matrix, such that locations that have been invaded by tumor cells in the past will subsequently experience a decline in 'tissue consistency' and thus in mechanical confinement:
• Cell behavior: the aforementioned dichotomy between growth and invasion [1, 2] in our model is captured by alternating sequences of "proliferation-migrationproliferation" behavior, which in turn drive the formation of distinct spatiotemporal patterns. Specifically, the onset of both proliferation and migration must satisfy the dual threshold levels of nutrients, ( L φ , U φ ), and toxicity, (
such that a tumor cell in location j proliferates if
, else the cell dies (representing apoptosis) or enters a reversible, quiescent state. For tumor cells that fail to fulfill the proliferation criteria but are eligible to migrate, they assign a value T j to a location j based on the following
where Ω is the set of locations that are adjacent to that tumor cell's current position, L j is the error-free component (the explicit specification of L j is derived in [3, 4] ), and ξ j is an error term distributed as N(0, σ least toxicity and highest attraction paradigm" the migrating tumor cell then moves toward the most permissive location j in the choice set Ω, i.e., arg
• Lattice setup: Based on this mathematical description, our simulation platform is initially setup as follows. As in previous works, our spatial backdrop is a 200 x 200 torroidal lattice, representing a virtual section of brain tissue. The initial spatial distributions of nutrients and mechanical confinements are detailed elsewhere [3, 4] . In brief, there are two replenished primary nutrient sources, representing cerebral blood vessels, located at the center and at the northeast (NE) quadrant of the lattice. To establish a strong chemotactic gradient, the peak of the second source at the NE quadrant is set up to be 5-times larger than that of the first source at the lattice center. Outside of these two sources, there are much smaller sources of non-replenished ('interstitial') nutrient substrates that are randomly-uniformly distributed. In contrast, we assume that the distribution of mechanical confinements follows a uniform distribution everywhere, except inside of a small 'crater' or void at the center of the grid lattice, adjacent to the first primary nutrient source. As in previous works, within the radius of the two primary nutrient sources, the initial levels of toxicity are assumed to be zero. As the tumor grows, the level of 'toxic' metabolites rises representing the reduction in pH and pO 2 in densely populated areas as well as the byproducts released from dying tumor cells. However, and unlike in previous works, outside of the radius of the two primary nutrient sources, here we introduce an initial distribution of toxic metabolites, representing here in addition the effect of 'hypoxia' that are already in the system from the beginning. These initial levels of hypoxia are generated based on a uniform probability distribution function. At the beginning of every simulation, the grid lattice is seeded with 10 tumor cells that are placed in the 'crater' at the center of the grid lattice. To facilitate initial invasion into the surrounding matrix, it is assumed that at t = 0 the crater exhibits low mechanical stresses and contains no nutrients. At t = 1, both nutrients and toxic metabolites start to diffuse into the crater due to declining mechanical constraints brought about by ('tissue architecture-disrupting') tumor cell invasion. The simulation terminates when the first tumor cell has reached the peak of the second primary nutrient source.
The following section details the experimental basis for the gene regulatory network operating at the molecular modeling level.
B. Experimental data and 'gene expression-environment interaction' concept
Using complementary DNA (cDNA) NIH microarrays, Mariani et al. [2] reported that the gene expression of Tenascin C is 4-fold up-regulated in human G112 glioma cells that were cultured on an extracellular matrix (ECM) derived from glioma cells. Moreover, compared to the control experiment, the authors found that these glioma cells exhibit a significantly accelerated migration rate of more than 250 µm/day. Concomitantly, that same migratory-stimulated glioma cells show a 2-3.5-fold down-regulation of PCNA.
Taken together, these findings finding suggest that the migratory phenotype in these glioma cells is associated with both up-regulation of Tenascin C and down-regulation of PCNA. [2] . Our approach is to first, calibrate the initial levels of Tenascin C and PCNA for migrating tumor cells in our agent-based model according to these data. The expression of these genes for proliferating (and quiescent) tumor cells is then obtained endogenously, i.e., as the output of our model. The impact of the microenvironmental conditions on gene expression is computed as follows.
• Tenascin C has been shown to be strongly expressed in human GaMG glioblastoma cells that were cultured in filtrated medium containing 10 percent fetal calf serum, yet showed a marked decrease when cultured in serum-free conditions [12] . In addition, with the use of serial analysis of gene expression (SAGE), Lal et al. [13] found that under hypoxic conditions, the gene encoding Tenascin C is induced in human D247-MG glioblastoma cells. Together, these findings suggest that an increase in both the onsite levels of nutrients ('serum') and toxicity ('hypoxia') leads to an increase of Tenascin gene expression for migrating tumor cells (see Table I ). Note that due to the absence of specific comparative experimental data, this formulation assigns equal, positive weights to both environmental variables.
• Folkman [14] had argued that for a tumor to exceed 2-3 mm in diameter, it requires angiogenesis as it relies on perfusion for further growth. Indeed, brain tumor cell proliferation is especially marked in perfused tumor areas [15] . As has been shown for osteoblasts, cell proliferation and thus PCNA expression should therefore decrease under hypoxic conditions [16] , such as in locations farther away from blood vessels, due to a lack of oxygen related to its diffusion limit of 100-200 µm [17] . Yet, like Tenascin C, the PCNA gene (promoter) also appears to be serum-responsive [18] . These data together suggest that an increase in nutrients and a decrease in hypoxia, i.e. toxicity lead to an increase of PCNA gene expression (gPCNA). Accordingly, we compute Table I) .
In the following section we will briefly describe the numerical results of the model.
RESULTS
The typical simulated time series of (a) Tenascin C and (b) PCNA for proliferating and migrating tumor cells from a typical run of our model is shown in Fig. 1 .
FIG. 1
The gene expression of Tenascin C for migrating cells is always higher than that for profile is accompanied by the emergence of a structural asymmetry, i.e., a bulging area on the tumor surface adjacent to the peak of the second primary nutrient source (located in the top right corner, i.e., the NE region of the lattice).
FIG. 2 FIG. 3
The time series depicted both in Figs. 1 and 2 exhibit both fluctuating "roughness" that could be described by a power law relationship, as well as non stationarity due to the changing means. To characterize the dynamic structure of the time series, we employ detrended fluctuation analysis (DFA) that has been previously developed to examine non-stationary signals [19] . Furthermore, DFA has been shown to be a robust method in detecting long-range correlations in heterogeneous DNA sequences [20, 21] . Briefly, the DFA method entails the following steps. Table II show the Monte Carlo simulation results from applying DFA to the time series of Tenascin C and PCNA gene expression in distinct regions of the tumor corresponding to (I) the entire tumor, (II) the NE region where the second nutrient source is located, and (III) the opposite, i.e. southwest (SW) region. Regardless of our region of interest (ROI), it can be seen that when DFA is applied separately to proliferating and migrating cells, the magnitude of α for proliferating cells indicates a stochastic process that is closer to a random walk. However, when DFA is applied to all viable tumor cells (i.e., including proliferating, migrating, and quiescent cells) for the entire tumor as well as the NE region, we find the magnitudes of α being significantly different from 0.5 for both gTenascin and gPCNA, indicating long-range power-law autocorrelation over the entire time series that is inherent in a dynamical system far from equilibrium. Thus, if we have the past realizations of aggregate gene expression in a sample taken from the NE ROI, we can compute the long-range autocorrelation α to predict the short-term trajectory of the structural pattern that is likely to emerge for that tumor region. Furthermore, these NE ROI sample is representative of the entire tumor, as evident from the magnitudes of α. In contrast, in the SW region, which contains only low-level nutrient sources, the magnitudes of α resemble those that have been generated by a random walk, and thus have little predictive values for both this particular ROI as well as the entire tumor.
TABLE II.
Columns (1) in
While DFA is a useful method to quantify the dynamic structure of a time series, it does not reveal the extent of the co-movements between a pair of variables. It turns out that the correlations between the tumor's macroscopic pattern and its molecular-level gene expression depend on both the timing and the geography of the sampling. For the entire time series, the correlation between the tumor diameter, which represents macroscopic structural characteristics, and gTenascin is 0.56 ± 0.05, while between the former and gPCNA is -0.52 ± 0.03, both are averages for all viable cells. At first, these rather low correlations seem to suggest a weak relationship between structural pattern and molecular-level dynamics. However, since the time series of gTenascin and gPCNA are both characterized by non-stationarity as indicated by the changing trend at the breakpoint (see Fig. 2) , it is necessary to split the series at the breakpoint and then compute the correlation coefficient from that point on, separately for each subsample of interest. Let In the following section we will briefly discuss these results and their potential impact on experimental and clinical oncology.
DISCUSSION AND CONCLUSIONS
Quantitative gene expression arrays provide novel and important information for experimental and clinical cancer research alike. However, since such arrays typically represent static snapshots taken at a given point in time from a specific specimen taken out of its 3D tissue context, they do not describe the dynamics on the molecular level and hence do not allow one to deduce their dynamic correlations with the overall expanding tumor structure the specimen has been taken from. Integrating this relationship between molecular-level gene expression and the macroscopic tumor structure within a dynamic framework therefore represents an important application for novel computational models, which one can begin to calibrate using already available tumor biology data.
For this purpose, here we have incorporated a gene expression module into a previously developed 2D agent-based tumor model which focuses on both the microscopic cellular level and the multicellular patterns arising from interactions with distinct environmental conditions. As a first approximation, this simplified genetic profile or 'network module' includes the expression of only two genes, Tenascin C and PCNA, respectively. Since specific expression levels have been reported for the migratory glioma cell phenotype, we calibrated the expression of genes Tenascin C and PCNA in our model for this phenotype only while endogenously obtaining the gene expression levels for the proliferative and quiescent phenotypes as the output of our model. Fig. 1 confirm that the Tenascin C gene expression experiences an up-regulation while PCNA is down-regulated during cell migration, whereas the PCNA gene expression is up-regulated during cell proliferation with a concomitantly down-regulated Tenascin C. The first part is in agreement with the cDNA data reported from [2] , implemented in the modeling concept. The proliferative part or, more precisely, the gene-network switch itself, leading to the change in phenotypic behavior can be explained by examining the environmental variables that govern the expression of Tenascin C and PCNA. Examination of nutrient and toxicity levels during a typical run reveals that as tumor cells begin to invade the second nutrient source, nutrient levels for migrating cells jump to a level 2.5-fold higher than those for proliferating cells, while toxic metabolites, representing in this iteration primarily hypoxic conditions (within our virtual 2D tissue section), reach a level 16-fold higher for migrating cells than those for proliferating cells. It is the simultaneous increases in nutrients and toxic metabolites that cause the breakpoint in the time series of the Tenascin C and PCNA expression (see Fig. 2 ). This intriguing behavior therefore can be explained by the explicit dependencies of gene expression in our model on environmental variables, which correspond to the fact reported in the literature that the expression of genes Tenascin C and PCNA depend positively on nutrient levels, yet only the Tenascin C is positively related to hypoxia levels while PCNA negatively so. However, it is noteworthy that none of the model equations impose the condition that the expression of genes Tenascin and PCNA in the proliferative cell population, which has been obtained as the output of our model, should remain at levels that are as remarkably stable over time as seen in Fig. 1 .
The results shown in
We also found that in the NE region where tumor cells are attracted by high levels of nutrient sources, representing for example the growth of the malignant brain tumor toward branches of the middle cerebral artery, the average tumor diameter exhibits a strong positive correlation with gTenascin, yet an equally strong negative correlation with gPCNA. Furthermore, our model also shows that this particular molecular-level behavior is accompanied by the emergence of a structural asymmetry, namely a bulging area, at the tumor surface adjacent to the largest nutrient source representing the aforementioned neighboring blood vessel. These computational findings are in agreement with Hoshino and Wilson [24] who stated that as a rule, an increase in brain tumor size is accompanied, amongst others, by a lower growth fraction, GF. As the total tumor cell number increases, and since the authors had defined GF as the proliferating pool cells divided by the total cell population, an additional decrease in PCNA expression as shown in our simulation results would contribute to an even more substantial GF reduction while the tumor diameter increases. Numerical results of our model confirm that gTenascin is upregulated among migrating cells (Fig. 1) to a level higher than for proliferating cells. Table II ], the computed α suggests dynamical behavior that is much closer to that of a random walk (i.e., with α = 0.5). Therefore, actual biopsy results that almost certainly contain all three tumor phenotypes (i.e., proliferating, migrating, and quiescent cells) appear to be more desirable than separate phenotypic subsets for gene expression profiling in generating time series whose past values can be utilized to predict future realizations, at least during a short-term duration. In contrast, predictions that are exclusively based on the gene expression for the proliferative cell phenotype appear to be relatively weak [columns (1) in Table II] ; hence the gene expression of this phenotype alone is less useful for detecting co-movements with structural macroscopic patterns [columns (2) in Table II ]. These findings thus suggest that biopsies from the proliferative tumor core are less useful for predicting macroscopic patterns than biopsies from the tumor edge, which should harbor a larger fraction of migratory phenotypes (i.e., contain a more heterogeneous mix of cell phenotypes). Furthermore, the magnitude of the α's also suggests the extent of autocorrelation is greater for gTenascin than for gPCNA; thus the prediction of gTenascin can be based on past values that had been recorded at larger inter-temporal interval than those required for the prediction of gPCNA while maintaining the same error level. This points towards potential implications for clinical oncology as it indicates that in order to predict the gene expression dynamics of Tenascin C in a patient's brain tumor, the interval between invasive control biopsies could in fact be kept longer, hence lowering the burden for the patient without jeopardizing the level of predictability. However, in a real medical setting it would be impossible to collect and analyze all tumor cells of a patient, and hence it is noteworthy that we found marked differences in the predictive value of distinct geographic regions within the tumor.
Specifically, the ROI NE closely represents the behavior of the entire tumor in terms of its DFA results whereas ROI SW does not. Taken together with the appearance of the surface asymmetry within the NE ROI, one could argue that in order to maximize its predictive value, a particular tumor tissue biopsy has to be prompted by the emergence of and then image-guided towards such conspicuous tumor rim regions.
It is important to realize the potential shortcomings of our approach. First, the precise nature of the gene regulatory network involving gTenascin and gPCNA is in large parts still unknown. However, even if more experimental information should become available in the future, it remains to be seen whether a model that incorporates the full complexity of the interactions among the genes involved in cell growth and locomotion would perform better than relatively simple models such as ours, which focuses on two 'key' genes only. Secondly, our model contains only a genetically homogeneous population of tumor cells, which is advantageous if the focus is on phenotypic alternations such as in here. Yet, a more biologically realistic model will eventually need to incorporate genetic instability and thus heterogeneity. Nonetheless, our goal here is to demonstrate that in this virtual brain tumor one can successfully combine the molecular-level gene expression dynamics with multicellular, macroscopic growth patterns using an agent-based modeling approach. As genomics data are becoming increasingly available for various tumor types our 'molmicro-macro' approach should provide a very helpful tool for investigating the crucial relationship between the phenotypic changes specific, microenvironmentally induced gene expression profiles cause on the one side and the expansion rate of the overall tumor system and its regional structural patterns on the other. 
